Results 211 to 220 of about 8,164,322 (359)

Utilization of adequate provision in prescription drug broadcast ads among low- and non-Internet users

open access: green, 2021
Kevin R. Betts   +4 more
openalex   +2 more sources

Use of proton-pump inhibitors among adults: a Danish nationwide drug utilization study

open access: yesTherapeutic Advances in Gastroenterology, 2016
A. Pottegård   +5 more
semanticscholar   +1 more source

Dual targeting of RET and SRC synergizes in RET fusion‐positive cancer cells

open access: yesMolecular Oncology, EarlyView.
Despite the strong activity of selective RET tyrosine kinase inhibitors (TKIs), resistance of RET fusion‐positive (RET+) lung cancer and thyroid cancer frequently occurs and is mainly driven by RET‐independent bypass mechanisms. Son et al. show that SRC TKIs significantly inhibit PAK and AKT survival signaling and enhance the efficacy of RET TKIs in ...
Juhyeon Son   +13 more
wiley   +1 more source

Drug utilization study of antiparkinsonian medication in Romania during 25 years. [PDF]

open access: yesFront Pharmacol
Bucsa C   +5 more
europepmc   +1 more source

Molecular characterisation of human penile carcinoma and generation of paired epithelial primary cell lines

open access: yesMolecular Oncology, EarlyView.
Generation of two normal and tumour (cancerous) paired human cell lines using an established tissue culture technique and their characterisation is described. Cell lines were characterised at cellular, protein, chromosome and gene expression levels and for HPV status.
Simon Broad   +12 more
wiley   +1 more source

Trends in Proton-Pump Inhibitor Use Among Danish Adults: A Nationwide Drug Utilization Study 2015-2023. [PDF]

open access: yesBasic Clin Pharmacol Toxicol
Lundgaard KM   +6 more
europepmc   +1 more source

A nationwide evaluation of off-label drug utilization in Turkey

open access: bronze, 2017
Emine Nur Özdamar   +4 more
openalex   +1 more source

Cis‐regulatory and long noncoding RNA alterations in breast cancer – current insights, biomarker utility, and the critical need for functional validation

open access: yesMolecular Oncology, EarlyView.
The noncoding region of the genome plays a key role in regulating gene expression, and mutations within these regions are capable of altering it. Researchers have identified multiple functional noncoding mutations associated with increased cancer risk in the genome of breast cancer patients.
Arnau Cuy Saqués   +3 more
wiley   +1 more source

Drug Utilization Review

open access: diamond, 2000
Sean Hennessy   +3 more
openalex   +1 more source

Home - About - Disclaimer - Privacy